Multidrug-resistant tuberculosis in children: Are the same therapy options available worldwide?

• Published in: International journal of infectious diseases Vol. 130; pp. S16 - S19
• Main Authors: Buonsenso, Danilo, Autore, Giovanni, Cusenza, Francesca, Passadore, Lucrezia, Bonanno, Francesca, Esposito, Susanna
• Format: Journal Article
• Language: English
• Published: Canada Elsevier Ltd 01.05.2023; Elsevier
• Subjects: Antitubercular Agents - pharmacology; Bedaquiline; Child; Children; Clinical Protocols; Delamanid; Humans; MDR-TB; Pediatric infectious diseases; Tuberculosis; Tuberculosis, Multidrug-Resistant - drug therapy; Tuberculosis, Multidrug-Resistant - epidemiology; MDR-TB; Tuberculosis; Children; Delamanid; Bedaquiline; Pediatric infectious diseases

•Drug-resistant tuberculosis (TB) in children mostly results from the transmission of resistant strains.•Providing access for children to appropriate TB treatments is mandatory.•Child-friendly formulations of second-line TB drugs should be developed.•More efforts should be done in facilitating drugs...